(2010). "Imaging lung manifestations of HIV/AIDS". Annals of Thoracic Medicine 5 (4): 201. DOI:10.4103/1817-1737.69106. ISSN 1817-1737. Creative Commons Attribution License

When Lung Cancer Occurs in Non-Smokers: An Exploration

• Post author:Jessica Lynn
• Post published:October 11, 2023
• Post category:Lung Cancer

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading When Lung Cancer Occurs in Non-Smokers: An Exploration

source: pixabay.com

ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer

• Post author:Rose Duesterwald
• Post published:October 2, 2023
• Post category:Lung Cancer

Over 50% of non-small cell lung cancer patients (NSCLC) will experience a recurrence after surgery. The cancer recurs even after adjuvant chemotherapy after major surgery. ALINA’s data show that Alecensa…

Continue Reading ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer

oracast / Pixabay

SNB-101 Nabs Orphan Drug Status for SCLC

• Post author:Jessica Lynn
• Post published:July 24, 2023
• Post category:Small cell lung cancer/Timely

According to an article from Akosua Mireku of Pharmaceutical Technology, the U.S. Food and Drug Administration recently granted Orphan Drug designation to SNB-101, a potential therapy for people living with…

Continue Reading SNB-101 Nabs Orphan Drug Status for SCLC

source: pixabay.com

28-Year-Old Alix Lived a Full Life in the Face ALK Positive Lung Cancer

• Post author:Rose Duesterwald
• Post published:March 8, 2023
• Post category:Lung Cancer

   In March of 2021, twenty-eight-year-old Alix Burnard of Newbury, Berkshire UK had several Covid-19 tests due to a suspected infection. All three tests were negative, so she felt it…

Continue Reading 28-Year-Old Alix Lived a Full Life in the Face ALK Positive Lung Cancer

Photo courtesy of Brittany

Advocating for Cancer Biomarker Testing: How Brittany Turned her RET+ NSCLC Diagnosis into Action (Pt. 2)

• Post author:Jessica Lynn
• Post published:November 18, 2022
• Post category:Rare Disease

Before you read further, make sure to check out Part 1 of our interview, where Brittany discusses what non-small cell lung cancer (NSCLC) is, her diagnostic journey, and how she learned that…

Continue Reading Advocating for Cancer Biomarker Testing: How Brittany Turned her RET+ NSCLC Diagnosis into Action (Pt. 2)

Photo courtesy of Brittany

Advocating for Cancer Biomarker Testing: How Brittany Turned her RET+ NSCLC Diagnosis into Action (Pt. 1)

• Post author:Jessica Lynn
• Post published:November 17, 2022
• Post category:non-small cell lung cancer/NSCLC

On the one-year anniversary of her RET+ non-small cell lung cancer (NSCLC) diagnosis, 37-year-old Brittany Hawkins had spent some time reflecting on her journey. When she was just seventeen years…

Continue Reading Advocating for Cancer Biomarker Testing: How Brittany Turned her RET+ NSCLC Diagnosis into Action (Pt. 1)

kalhh / Pixabay

Researchers Identify Gene that Activates P-Subtype SCLC

• Post author:Jessica Lynn
• Post published:November 3, 2022
• Post category:Small cell lung cancer

  Unfortunately, there are no cures - nor effective treatment options - for individuals with P-subtype small cell lung cancer (SCLC). This subtype is notoriously treatment-averse; it is also relatively…

Continue Reading Researchers Identify Gene that Activates P-Subtype SCLC

New ALK-Positive Lung Cancer Patient Resource from LUNGevity

• Post author:Alyssa Stevens
• Post published:April 22, 2022
• Post category:Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

According to a recent article, LUNGevity has just launched a resource platform that provides information, news, and community for patients diagnosed with ALK-positive lung cancer. ALK Positive Lung Cancer Anaplastic…

Continue Reading New ALK-Positive Lung Cancer Patient Resource from LUNGevity

Photo by Robina Weermeijer on Unsplash

$1 Million Combined Grant Given to Study RET-Positive Lung Cancer

• Post author:Alyssa Stevens
• Post published:March 29, 2022
• Post category:Cancer

According to a recent article, the Hamoui Foundation and LUNGevity Foundation granted $1 million to three researchers in order to study RET-positive lung cancer. RET-Positive Lung Cancer There are two…

Continue Reading $1 Million Combined Grant Given to Study RET-Positive Lung Cancer

source: pixabay.com

Metastatic NSCLC Survival Boosted by Dual Immunotherapy

• Post author:Alyssa Stevens
• Post published:November 16, 2021
• Post category:Rare Disease

  According to a recent article, the overall survival of patients with untreated metastatic non-small cell lung cancer (NSCLC) were significantly improved by the addition of two immunotherapeutic drugs to…

Continue Reading Metastatic NSCLC Survival Boosted by Dual Immunotherapy

source: pixabay.com

Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma

• Post author:Kendall Mason
• Post published:May 19, 2021
• Post category:Malignant pleural mesothelioma

Based on new data, the European Medicines Agency’s Committee for Medicinal Products for Human Use has designated nivolumab and ipilimumab as the frontline treatment for malignant pleural mesothelioma (MPM) in…

Continue Reading Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma

source: pixabay.com

Pleural Mesothelioma Study Evaluates Prolonged Survival

• Post author:James Moore
• Post published:May 18, 2021
• Post category:Mesothelioma

According to a story from asbestos.com, patients surviving for five years or more with pleural mesothelioma is still uncommon. However, in those that do, exposure to lower levels of asbestos…

Continue Reading Pleural Mesothelioma Study Evaluates Prolonged Survival

source: pixabay.com

Ronnie Wood of the Rolling Stones Faced Small Cell Lung Cancer During COVID

• Post author:James Moore
• Post published:May 6, 2021
• Post category:Small cell lung cancer

According to a story from MSN, 73 year old Ronnie Wood of the Rolling Stones recently discussed in an interview his struggle with small cell lung cancer during the COVID-19…

Continue Reading Ronnie Wood of the Rolling Stones Faced Small Cell Lung Cancer During COVID

2020 Brought Exciting Advances in Lung Cancer Care

• Post author:Rose Duesterwald
• Post published:January 27, 2021
• Post category:Small cell lung cancer

Although advances in lung cancer care were overshadowed this year by news about the pandemic, Dr. Jennifer Carlisle’s recent interview with Oncology gave details of spectacular advances in lung cancer…

Continue Reading 2020 Brought Exciting Advances in Lung Cancer Care

kalhh / Pixabay

ALUNBRIG Approved by European Commission as Treatment for Patients with ALK+ NSCLC

• Post author:Jessica Lynn
• Post published:April 10, 2020
• Post category:Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

  According to a release on Biospace, the European Commission (EC) has approved Takeda Pharmaceutical's ALUNBRIG (brigatinib) as treatment for patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer…

Continue Reading ALUNBRIG Approved by European Commission as Treatment for Patients with ALK+ NSCLC

oracast / Pixabay

EMA Recommends ALUNBRIG for the Treatment of Non-Small Cell Lung Cancer

• Post author:Kendall Mason
• Post published:March 5, 2020
• Post category:Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

The European Medicines Agency has recently released their positive opinion of ALUNBRIG, which is a treatment for anaplastic lymphoma kinase+ (ALK+) non-small cell lung cancer (NSCLC). They have recommended this…

Continue Reading EMA Recommends ALUNBRIG for the Treatment of Non-Small Cell Lung Cancer